Distinct Healthcare

Distinct Healthcare (Ticker: 2677 HK) provides private medical services through a care model combining in-person and telehealth services for the mass-affluent population. It operates 19 institutions across major Chinese cities, including clinics and hospitals, and has additional clinics in Singapore and Malaysia. Notable shareholders include Tencent Holdings and Tian Tu Capital. Planned uses of IPO proceeds include research and development, expanding product capacity, strategic acquisitions and general working capital.

The scheduled listing date on Hong Kong Stock Exchange was February 6, 2026. The proposed offering comprises 4,750,000 shares at an indicative price range of HKD 57.70–66.60 per share. At the indicative range midpoint, the base offering would represent HKD 295.21 million, approximately $37.62 million in gross proceeds, excluding any unexercised over-allotment. The indicated IPO market capitalization is HKD 3.71–4.29 billion, approximately $472.74–546.64 million.

SPDB International Capital and Haitong International Capital are joint sponsors.